Case report on a case of sole i(4)(p10) in myelodysplastic syndrome.
Cyto-Pathology Classification
Cytology Refractory anemia with excess blasts (RAEB) Diagnosis RAEB2 (WHO 2008) Desangles F, et al. Atlas Genet Cytogenet Oncol Haematol. 2014; 18(2) 
147

Comments
We present a new case of isochromosome 4p in a myeloid proliferation. The patient, a 79 years old man developed an MDS (RAEB2), occurring 20 years after an acute myeloid leukemia not otherwise documented. Cytogenetics on bone marrow aspirate revealed a unique abnormality in the karyotype, an additional isochromosome 4p. FISH with wpc4 and FGFR3 probes confirmed the i(4p) as an extra chromosome. The most frequent molecular/cytogenetic abnormalities in myeloid proliferations were absent: 5q31, 7q22-q31 probes (for del 5q or del 7q) and ETO + AML1 probes (for +8 or +21) showed no abnormality. To our knowledge, this is the sixth reported case of myeloid proliferation with an isochromosome 4p as the sole karyotype abnormality. The previous published cases were M4-AML (3 cases), M2-AML (1 case) and RAEB-T (1 case) (Hagemeijer et al., 1981; Hoo et al., 1995; Chen et al., 1999; Soriani et al., 2010) . In this short series, only one relapse is recorded after 9 months, it is the unique case of double i(4p); two cases are noted as being in complete remission and two are not documented. The present case is not relevant to the prognosis value of this karyotype anomaly: first, to date the duration of treatment is only three months, but also the age of the patient, and a previous history of AML are factors which impact the prognosis too greatly by themselves. Isochromosome 4p currently does not have a specific prognostic value in myeloid proliferations. At the present time, what interpretation of i(4)(p10) can be proposed? "Considering that trisomy 4 as the sole abnormality of karyotype is common anomalies in AML and MDS", Chen et al. (1999) suppose that "amplification of genes on 4p but not on 4q may play a crucial role in the pathogenesis of MDS and AML". Recently, two genes located on chromosome 4 were identified as playing a role in myeloid proliferations. In 2003, Dvorak et al. have described the increased expression of FGFR3 (4p16), a member of the family of tyrosine kinase genes, in myeloid proliferating cells of CML and AML. Furthermore TET2 in 4q24 is a putative tumor suppressor in myeloid proliferations (Delhommeau et al., 2009; Jankowska et al., 2009 , Vainchenker et al., 2011 . Thus it can be assumed that the presence of a supernumerary isochromosome 4p can increase the expression of FGFR3 in 4p16 without increasing the copy number of the tumor suppressor gene TET2 in 4q24. Call for Collaborations francoisdesangles@hotmail.com Desangles F, et al. Atlas Genet Cytogenet Oncol Haematol. 2014; 18(2) 148 Desangles F, et al. Atlas Genet Cytogenet Oncol Haematol. 2014; 18(2) 
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